Bodybuilding – Drugs vs Diet Pt. 1 – Interview with IFBB Pro and Dietitian Chris Tuttle

Doctor Thomas OConnor opens by framing a common bodybuilding argument, asking whether drugs or diet explains professional physiques. Chris Tuttle is introduced as an IFBB professional and dietitian, and the discussion quickly shifts toward how misinformation spreads online. They describe how internet forums often publish supposed professional cycles, even when the details are secondhand and unreliable. Chris argues that the gap between elite amateurs and true professionals is usually genetics, not simply doubling drug doses. When a young gym goer copies a posted cycle, the results rarely match because body size, metabolism, and responsiveness differ greatly. The conversation emphasizes that many people assume bigger athletes must be lying if the listed doses look moderate. They present this as a cultural problem because it encourages escalation instead of learning fundamentals first.

When they discuss an offseason approach, Chris says forums commonly mention testosterone, Deca, and Dianabol as a basic template. They react to claims of fifteen hundred milligrams of testosterone weekly, noting that extremes become normalized in comment threads. As the topic moves toward contest preparation, Chris explains that cutting length depends on starting body fat and progress during diet and cardio. He describes how testosterone often stays in the plan, while estrogen conversion may be managed with an aromatase inhibitor strategy. They mention adding Masteron propionate and trenbolone acetate as examples of injectables that appear during later preparation phases. The discussion also touches on bodybuilding belly theories, suggesting that massive food intake and weak core stability can contribute. They connect the issue to polypharmacy, specifically pairing growth hormone and insulin with high calorie intake during bulking.

Doctor OConnor explains that the modern landscape includes many agents beyond classic steroids, including thyroid preparations, diuretics, and metformin. They stress that using multiple drugs without physician oversight increases risk because dosing decisions are often based on hearsay. The conversation then turns to blasting and cruising language, where a so called TRT cruise can still mean four to six hundred milligrams weekly. He notes that some men aim closer to two hundred milligrams, but individual genetics and delivery methods change steady state levels. They explain why avoiding large peaks and troughs matters, because stability can support brain function and libido more predictably. Post cycle therapy is discussed as a separate topic, and tamoxifen is named alongside hCG as commonly referenced options. They close by setting up a future diet focused segment, reinforcing that nutrition decisions must adapt to drug exposure and body changes.